Drug Patents owned by Wyeth Pharms

1. Drug name - DUAVEE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7683051 WYETH PHARMS Crystalline polymorph of bazedoxifene acetate
Mar, 2027

(4 years from now)

CN1938272A WYETH PHARMS The Crystal Polymorphic Form Of The Bazedoxifene Acetate
Jan, 2010

(12 years ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6479535 WYETH PHARMS 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations May, 2024

(1 year, 7 months from now)

Drugs and Companies using BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED ingredient

Treatment: Prevention of postmenopausal osteoporosis; treatment of moderate to severe vasomotor symptoms associated with menopause

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 20MG BASE;0.45MG TABLET;ORAL Prescription

2. Drug name - PROTONIX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7838027 WYETH PHARMS Pantoprazole multiparticulate formulations Sep, 2024

(1 year, 11 months from now)

US7550153 WYETH PHARMS Pantoprazole multiparticulate formulations Sep, 2024

(1 year, 11 months from now)

US7553498 WYETH PHARMS Pantoprazole multiparticulate formulations Sep, 2024

(1 year, 11 months from now)

US7553498

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations Mar, 2025

(2 years from now)

US7550153

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations Mar, 2025

(2 years from now)

US7838027

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations Mar, 2025

(2 years from now)

US7544370 WYETH PHARMS Pantoprazole multiparticulate formulations Jun, 2026

(3 years from now)

US7544370

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations Dec, 2026

(4 years from now)

Drugs and Companies using PANTOPRAZOLE SODIUM ingredient

Treatment: Erosive esophagitis, hypersecretory conditions including zollinger-ellison syndrome, maintenance of healing of erosive esophagitis and reduction of symptoms in patients with gerd

Dosage: FOR SUSPENSION, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 40MG BASE FOR SUSPENSION, DELAYED RELEASE;ORAL Prescription

3. Drug name - ZOSYN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8133883 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection Apr, 2023

(6 months from now)

US6900184 WYETH PHARMS Compositions containing pipercillin and tazobactam useful for injection Apr, 2023

(6 months from now)

US7915229 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection Apr, 2023

(6 months from now)

Drugs and Companies using PIPERACILLIN SODIUM; TAZOBACTAM SODIUM ingredient

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

More Information on Dosage
Strength Dosage Availability
EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL INJECTABLE;INJECTION Discontinued
EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL INJECTABLE;INJECTION Discontinued
EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL INJECTABLE;INJECTION Discontinued
EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL INJECTABLE;INJECTION Discontinued

4. Drug name - ZOSYN IN PLASTIC CONTAINER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7915229 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection Apr, 2023

(6 months from now)

US8133883 WYETH PHARMS Compositions containing piperacillin and tazobactam useful for injection Apr, 2023

(6 months from now)

US6900184 WYETH PHARMS Compositions containing pipercillin and tazobactam useful for injection Apr, 2023

(6 months from now)

Drugs and Companies using PIPERACILLIN SODIUM; TAZOBACTAM SODIUM ingredient

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

More Information on Dosage
Strength Dosage Availability
EQ 4GM BASE/100ML;EQ 500MG BASE/100ML INJECTABLE;INJECTION Prescription
EQ 40MG BASE/ML;EQ 5MG BASE/ML INJECTABLE;INJECTION Prescription
EQ 60MG BASE/ML;EQ 7.5MG BASE/ML INJECTABLE;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.